CMAC Industry Director (232859)
 

Salary Range: Competitive 
FTE: 1 (35 hours/week) 
Term: Fixed Term (4 years) 
Closing date: 25/08/2019 


The Continuous Manufacturing and Advanced Crystallisation (CMAC) Hub is a world-class centre of excellence for advanced pharmaceutical manufacturing research and training. As an EPSRC Future Manufacturing Research Hub, led by the University of Strathclyde we work in close collaboration with a number of spokes at leading UK academic institutions (Bath, Cambridge, Imperial College, Leeds, Loughborough, Sheffield) and linking with international centres in the US, Europe and Far East. Working in partnership with industry, CMAC’s purpose is to transform the development and manufacture of medicines through advanced design and manufacturing technologies including the development of digital twins and microfactories. The four key pillars of CMAC’s program are to: deliver high quality manufacturing research; develop the workforce of the future through skills development and training; to drive effective translation of research into industry and, to continue to develop our world leading facilities and lab of the future infrastructure. As part of the University of Strathclyde, CMAC is also a strategic research partner for the Centre for Process Innovation’s (CPI) recently established Medicines Manufacturing Innovation Centre (MMIC).
 
CMAC’s demand led vision has been developed through close collaboration with our Tier 1 industry partners (GlaxoSmithKline, AstraZeneca, Novartis, Bayer, Takeda, Lilly, Pfizer, Roche) and a wide range of technology companies. Established in 2011, CMAC has contributed to a £150m funding portfolio and currently comprises more than 130 staff and researchers, including academics, post docs, over 70 PhD students as well as an experienced support team. Building on significant capital investments CMAC has established the National Facility team to broaden our ability to support and engage a wide user community within the £90M Technology & Innovation Centre (TIC) building at Strathclyde.

CMAC are looking to appoint an Industry Director who will deliver best in class industry engagement, grow a sustainable pipeline of industry funding to support delivery of CMAC strategy, identify opportunities for alignment of research areas and funding that meet end user needs, advocate and promote the Hub and research base to industrial users and identify new funding opportunities. The successful candidate will bring  extensive relevant leadership experience within pharmaceutical or related industry and/or at the academic/industry interface, demonstrating professional development through a series of progressively more demanding and influential work roles.

Formal interviews for this post will be held in September. 

For informal enquires please contact Professor Alastair Florence, CMAC Director (alastair.florence@strath.ac.uk).

Click here for full details
Faculty
Faculty of Science
Department/School
Strathclyde Institute of Pharmacy and Biomedical Sciences
Staff Category
Administrative and Professional Services
Type of Employment
Fixed-term
Working Hours
Full-time
Vacancy Description
 
Salary Range: Competitive 
FTE: 1 (35 hours/week) 
Term: Fixed Term (4 years) 
Closing date: 25/08/2019 


The Continuous Manufacturing and Advanced Crystallisation (CMAC) Hub is a world-class centre of excellence for advanced pharmaceutical manufacturing research and training. As an EPSRC Future Manufacturing Research Hub, led by the University of Strathclyde we work in close collaboration with a number of spokes at leading UK academic institutions (Bath, Cambridge, Imperial College, Leeds, Loughborough, Sheffield) and linking with international centres in the US, Europe and Far East. Working in partnership with industry, CMAC’s purpose is to transform the development and manufacture of medicines through advanced design and manufacturing technologies including the development of digital twins and microfactories. The four key pillars of CMAC’s program are to: deliver high quality manufacturing research; develop the workforce of the future through skills development and training; to drive effective translation of research into industry and, to continue to develop our world leading facilities and lab of the future infrastructure. As part of the University of Strathclyde, CMAC is also a strategic research partner for the Centre for Process Innovation’s (CPI) recently established Medicines Manufacturing Innovation Centre (MMIC).
 
CMAC’s demand led vision has been developed through close collaboration with our Tier 1 industry partners (GlaxoSmithKline, AstraZeneca, Novartis, Bayer, Takeda, Lilly, Pfizer, Roche) and a wide range of technology companies. Established in 2011, CMAC has contributed to a £150m funding portfolio and currently comprises more than 130 staff and researchers, including academics, post docs, over 70 PhD students as well as an experienced support team. Building on significant capital investments CMAC has established the National Facility team to broaden our ability to support and engage a wide user community within the £90M Technology & Innovation Centre (TIC) building at Strathclyde.

CMAC are looking to appoint an Industry Director who will deliver best in class industry engagement, grow a sustainable pipeline of industry funding to support delivery of CMAC strategy, identify opportunities for alignment of research areas and funding that meet end user needs, advocate and promote the Hub and research base to industrial users and identify new funding opportunities. The successful candidate will bring  extensive relevant leadership experience within pharmaceutical or related industry and/or at the academic/industry interface, demonstrating professional development through a series of progressively more demanding and influential work roles.

Formal interviews for this post will be held in September. 

For informal enquires please contact Professor Alastair Florence, CMAC Director (alastair.florence@strath.ac.uk).

Click here for full details